Aarti Pharmalabs Ltd.

The revenue for the March 2024 quarter is pegged at Rs. 4148.20 millions, about 10.83% up against Rs. 3742.70 millions recorded during the year-ago period.Profit for the quarter ended March 2024 rises by 57.59% to Rs. 630.20  millions from Rs. 399.90 millions.Operating profit surged to 1130.20 millions from the corresponding previous quarter of 768.00 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202403	202303	% Var	202403	202303	% Var	202403	202303	% Var
Sales	4148.20	3742.70	10.83	15021.30	15112.50	-0.60	15021.30	15112.50	-0.60
Other Income	56.80	0.00	0.00	110.10	12.80	760.16	110.10	12.80	760.16
PBIDT	1130.20	768.00	47.16	3571.60	3096.20	15.35	3571.60	3096.20	15.35
Interest	44.20	58.00	-23.79	166.30	204.90	-18.84	166.30	204.90	-18.84
PBDT	1086.00	710.00	52.96	3405.30	2891.30	17.78	3405.30	2891.30	17.78
Depreciation	173.20	142.50	21.54	660.10	557.70	18.36	660.10	557.70	18.36
PBT	912.80	567.50	60.85	2745.20	2333.60	17.64	2745.20	2333.60	17.64
TAX	282.60	167.60	68.62	738.70	616.30	19.86	738.70	616.30	19.86
Deferred Tax	165.60	27.60	500.00	278.10	95.00	192.74	278.10	95.00	192.74
PAT	630.20	399.90	57.59	2006.50	1717.30	16.84	2006.50	1717.30	16.84
Equity	453.10	453.10	0.00	453.10	453.10	0.00	453.10	453.10	0.00
PBIDTM(%)	27.25	20.52	32.78	23.78	20.49	16.05	23.78	20.49	16.05